Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 3, 2006 - Issue 5
Submit an article Journal homepage
110
Views
13
CrossRef citations to date
0
Altmetric
Technology Evaluation

Dose accuracy of a reusable insulin pen using a cartridge system with an integrated plunger mechanism

Alastair Clarke Head of Device Design & Industrialisaton, sanofi-aventis, Deutschland GmbH, Industriepark Hoechst, Building K607, 65843 Frankfurt am Main, Germany. [email protected]
&
Marie-Paule Dain Diabetes Medical Director, Global Metabolism, sanofi-aventis, Paris, France
Pages 677-683 | Published online: 01 Sep 2006

Bibliography

  • WILD S, ROGLIC G, GREEN A, SICREE R, KING H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 27(5):1047-1053.
  • WRIGHT A: Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with Type 2 diabetes in the UK. Prospective Diabetes Study (UKPDS 57). Diabetes Care (2002) 25(2):330-336.
  • RIDDLE MC: Timely addition of insulin to oral therapy for Type 2 diabetes. Diabetes Care (2002) 25(2):395-396.
  • RIDDLE MC: Timely initiation of basal insulin. Am. J. Med. (2004) 116(Suppl. 3A):3S-9S.
  • SUMMERS KH, SZEINBACH SL, LENOX SM: Preference for insulin delivery systems among current insulin users and nonusers. Clin. Ther. (2004) 26(9):1498-1505.
  • BOHANNON NJ: Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad. Med. (1999) 106(5):57-58, 61-64, 68.
  • COSTA SD, BRACKENRIDGE B, HICKS D: A comparison of insulin pen use in the United States and the United Kingdom. Diabetes Educ. (2002) 28(1):52-56, 59-60.
  • KORYTKOWSKI M, BELL D, JACOBSEN C, SUWANNASARI R: A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with Type 1 or 2 diabetes mellitus. Clin. Ther. (2003) 25(11):2836-2848.
  • SHELMET J, SCHWARTZ S, CAPPLEMAN J et al.: Preference and resource utilization in elderly patients: InnoLet versus vial/syringe. Diabetes Res. Clin. Pract. (2004) 63(1):27-35.
  • KADIRI A, CHRAIBI A, MAROUAN F et al.: Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res. Clin. Pract. (1998) 41(1):15-23.
  • HANAS S, LUDVIGSSON J: Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract. Diabetes Int. (1997) 14:95-99.
  • LTEIF AN, SCHWENK WF: Accuracy of pen injectors versus insulin syringes in children with Type 1 diabetes. Diabetes Care (1999) 22(1):137-140.
  • PLEVIN S, SADUR C: Use of a prefilled insulin syringe (Novolin Prefilled) by patients with diabetes. Clin. Ther. (1993) 15(2):423-431.
  • COSCELLI C, LOSTIA S, LUNETTA M, NOSARI I, CORONEL GA: Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res. Clin. Pract. (1995) 28(3):173-177.
  • CORSI A, TORRE E, CORONEL G et al.: Pre-filled insulin pen in newly insulin-treated diabetic patients over 60 years old. Diabetes Nutr. Metab. (1997) 10:78-81.
  • AYLWARD GW: Progressive changes in diabetics and their management. Eye (2005) 19(10):1115-1118.
  • CASANOVA JE, CASANOVA JS, YOUNG MJ: Hand function in patients with diabetes mellitus. South Med. J. (1991) 84(9):1111-1113.
  • STARKMAN HS, GLEASON RE, RAND LI, MILLER DE, SOELDNER JS: Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann. Rheum. Dis. (1986) 45(2):130-135.
  • CRYER PE: Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia (2002) 45(7):937-948.
  • DAVIDSON JA: Treatment of the patient with diabetes: importance of maintaining target HbA(1c) levels. Curr. Med. Res. Opin. (2004) 20(12):1919-1927.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.